Filing Details
- Accession Number:
- 0001209191-22-043395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-28 17:02:41
- Reporting Period:
- 2022-07-26
- Accepted Time:
- 2022-07-28 17:02:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1258693 | Grant Pickering | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-26 | 5,000 | $23.26 | 167,830 | No | 4 | S | Indirect | By Children's Trust |
| Common Stock | Disposition | 2022-07-26 | 5,000 | $23.27 | 167,830 | No | 4 | S | Indirect | By Children's Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Children's Trust |
| No | 4 | S | Indirect | By Children's Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 683,456 | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $22.99 to $23.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $22.965 to $23.79. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's son.
Billionaire Hedge Funds
